imiquimod has been researched along with quercetin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Ito, K; Kawabe, T; Kodera, Y; Kojima, S; Matsushima, M; Mori, K; Ogasawara, N; Omura, A; Shiga, M; Yasui, M | 1 |
Chen, H; Han, L; Liu, H; Lu, C; Wang, M; Yan, Y; Zhao, H | 1 |
Du, Z; Li, N; Lu, C; Wu, D; Yuan, X; Zhang, M; Zhu, W | 1 |
Chen, Z; Di, T; Li, P; Wang, Y; Zhai, C; Zhao, J | 1 |
5 other study(ies) available for imiquimod and quercetin
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The Suppressive Effect of Quercetin on Toll-Like Receptor 7-Mediated Activation in Alveolar Macrophages.
Topics: Aminoquinolines; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Cell Culture Techniques; Cell Line; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Heme Oxygenase-1; Imiquimod; Ligands; Macrophage Activation; Macrophages, Alveolar; Membrane Glycoproteins; Membrane Proteins; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); Quercetin; Signal Transduction; Toll-Like Receptor 7 | 2015 |
Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents; Catalase; Cytokines; Glutathione; Imiquimod; Male; Malondialdehyde; Mice, Inbred BALB C; NF-kappa B; Psoriasis; Quercetin; Signal Transduction; Skin; Superoxide Dismutase | 2017 |
Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2/STAT3 signal pathways.
Topics: Animals; Cell Line; Cell Proliferation; Cyclosporine; Cytokines; Dermatitis; Humans; Imiquimod; Inflammation; Janus Kinase 2; Keratinocytes; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Models, Animal; Psoriasis; Quercetin; Receptor, Notch1; Signal Transduction; Skin; STAT3 Transcription Factor; T-Lymphocytes; Transcription Factors | 2020 |
Taxifolin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like mouse model via regulating cytoplasmic phospholipase A2 and PPAR-γ pathway.
Topics: Animals; Cell Line; Cell Proliferation; Cytoplasm; Disease Models, Animal; Down-Regulation; Humans; Imiquimod; Keratinocytes; Male; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Phospholipases A2; Phosphorylation; PPAR gamma; Proteomics; Psoriasis; Quercetin; Signal Transduction | 2021 |